"Missioklinik und Juliusspital bilden gemeinsam das Klinikum Würzburg Mitte, ein modernes Klinikum mit zwei traditionsreichen Standorten. Als Krankenhaus der Schwerpunktversorgung bietet das KWM ein umfassendes medizinisches Behandlungsspektrum. Die mehr als 2.200 Mitarbeiter*innen des KWM versorgen jährlich etwa 30.000 Patienten."

During the past decade, Klinikum Würzburg Mitte gGmbH Standort Missioklinik conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik" are "Pulmonary Arterial Hypertension" (2 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials), "Non-Small Cell Lung Cancer (NSCLC)" (1 trials) and "Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)" (1 trials). Many other conditions were trialed in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik" in a lesser frequency.

Most popular intervention types in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Selexipag" (2 trials), "Atezolizumab" (1 trials), "FDC macitentan/tadalafil" (1 trials) and "Macitentan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Würzburg Mitte gGmbH Standort Missioklinik". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Klinikum Würzburg Mitte gGmbH Standort Missioklinik, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Würzburg Mitte gGmbH Standort Missioklinik, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".